Navignostics
Navignostics
We fight cancer by enabling personalized treatments. Navignostics analyzes tumor tissue to identify the best therapeutic options for each patient and supports drug developers and researchers in selecting the right patients for clinical studies.
What we do
We analyze tumor samples and determine the most effective way to target each cancerous growth so clinicians can find the right therapy for their patients and researchers can develop better drugs.
Technology & services
- Diagnostics: identify optimal therapy from a single tumor tissue section
- Research: support translational research and biomarker identification for clinical trials
- Spatial single-cell proteomics combining highly multiplex protein imaging with advanced data analytics
Headquarters & founding
Founded in 2022 as a spin-off from the University of Zurich Bodenmiller Lab. Laboratory and headquarters in Horgen, Switzerland.
